Literature DB >> 2395638

Trans-splicing of pre-mRNA is predicted to occur in a wide range of organisms including vertebrates.

T Dandekar1, P R Sibbald.   

Abstract

Several known trans-splicing RNA structures were used to define a canonical trans-splicing structure which was then used to perform a computer search of the EMBL nucleotide database. In addition to most known trans-splicing structures, many putative new trans-splicing sites were detected. These were found in a broad range of organisms including the vertebrates. Control experiments indicate that the search predicts known false positives at a rate of only 20%. Trans-splicing may therefore be a very wide-spread phenomenon.

Mesh:

Substances:

Year:  1990        PMID: 2395638      PMCID: PMC331928          DOI: 10.1093/nar/18.16.4719

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Discontinuous RNA synthesis through trans-splicing.

Authors:  R Braun
Journal:  Bioessays       Date:  1986-11       Impact factor: 4.345

2.  Evidence for in vivo trans splicing of pre-mRNAs in tobacco chloroplasts.

Authors:  B Koller; H Fromm; E Galun; M Edelman
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

3.  Discontinuous transcription and splicing in trypanosomes.

Authors:  L H Van der Ploeg
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Trans splicing: variation on a familiar theme?

Authors:  P A Sharp
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

Review 5.  Antigenic variation in African trypanosomes.

Authors:  J C Boothroyd
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

6.  Single base substitution in an intron of oxidase gene compensates splicing defects of the cytochrome b gene.

Authors:  G Dujardin; C Jacq; P P Slonimski
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

7.  Ordered processing and splicing in a polycistronic transcript in liverwort chloroplasts.

Authors:  T Kohchi; Y Ogura; K Umesono; Y Yamada; T Komano; H Ozeki; K Ohyama
Journal:  Curr Genet       Date:  1988-08       Impact factor: 3.886

8.  The monogenetic kinetoplastid protozoan, Crithidia fasciculata, contains a transcriptionally active, multicopy mini-exon sequence.

Authors:  M L Muhich; D E Hughes; A M Simpson; L Simpson
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

9.  Comparison of the genes coding for the common 5' terminal sequence of messenger RNAs in three trypanosome species.

Authors:  T De Lange; T M Berkvens; H J Veerman; A C Frasch; J D Barry; P Borst
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

10.  Identification of a small RNA containing the trypanosome spliced leader: a donor of shared 5' sequences of trypanosomatid mRNAs?

Authors:  M Milhausen; R G Nelson; S Sather; M Selkirk; N Agabian
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

View more
  5 in total

1.  A software tool-box for analysis of regulatory RNA elements.

Authors:  Peter Bengert; Thomas Dandekar
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Homologous SV40 RNA trans-splicing: a new mechanism for diversification of viral sequences and phenotypes.

Authors:  Joachim Eul; Volker Patzel
Journal:  RNA Biol       Date:  2013-10-14       Impact factor: 4.652

3.  rRNA-like sequences occur in diverse primary transcripts: implications for the control of gene expression.

Authors:  V P Mauro; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver.

Authors:  C Caudevilla; D Serra; A Miliar; C Codony; G Asins; M Bach; F G Hegardt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Experimental evidence for RNA trans-splicing in mammalian cells.

Authors:  J Eul; M Graessmann; A Graessmann
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.